Camaryolic acid



Compound IDCDAMM01782
Common nameCamaryolic acid
IUPAC name20-methoxy-7,8,14,15,19,19-hexamethyl-10-(2-methylbut-2-enoyloxy)-21-oxahexacyclo[18.2.2.01,18.02,15.05,14.06,11]tetracos-4-ene-11-carboxylic acid
Molecular formulaC36H54O6

Experimental data

Retention time14.95
Adduct[M+H]+
Actual mz583.402
Theoretical mz583.399
Error5.01
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.5451

Identifiers and class information

Inchi keyVXRPFQZOVJGGIP-YHQSEXEHNA-N
SmilesO=C(OC1CC(C)C(C)C2C3=CCC4C(C)(CCC5C(C)(C)C6(OC)OCC45CC6)C3(C)CCC12C(=O)O)C(=CC)C
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)4
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)1
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)4
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-1
Molecular weight (mol_MW)582.819
Computed dipole moment(dipole)6.046
Total solvent accessible surface area (SASA)865.58
Hydrophobic component of SASA (FOSA)757.8
Hydrophilic component of SASA (FISA)83.355
Pie component of the SASA (PISA)24.425
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1748.74
Number of hydrogen bond donors (donorHB)1
Number of hydrogen bond acceptors (accptHB)5.5
Free energy of solvation of dipole (dip^2/V)0.0209047
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0063541
Globularity descriptor (glob)0.810976
Predicted polarizability in cubic angstroms (QPpolrz)61.495
Predicted hexadecane/gas partition coefficient (QPlogPC16)15.243
Predicted octanol/gas partition coefficient (QPlogPoct)25.024
Predicted water/gas partition coefficient (QPlogPw)8.535
Predicted octanol/water partition coefficient (QPlogPo/w)7.975
Predicted aqueous solubility (QPlogS)-9.322
Conformation-independent predicted aqueous solubility (CIQPlogS)-9.002
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-2.9
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)406.484
Predicted brain/blood partition coefficient (QPlogBB)-0.523
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)237.799
Predicted skin permeability, log Kp (QPlogKp)-2.586
PM3 calculated ionization potential (IP(ev))9.954
PM3 calculated electron affinity (EA(eV))0.033
Number of likely metabolic reactions (#metab)4
Prediction of binding to human serum albumin (QPlogKhsa)1.983
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)94.419
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)87.008
Number of nitrogen and oxygen atoms (#NandO)6
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P18031PTPN1Protein-tyrosine phosphatase 1BT16347SEA
P17706PTPN2T-cell protein-tyrosine phosphataseT49156SEA
P13726F3Coagulation factor VII/tissue factorT72702SEA
P16885PLCG2Phospholipase C-gamma-2T93922SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16347DI0009Acute diabete complication[ICD-11: 5A2Y]P18031PTPN1
T16347DI0062Breast cancer[ICD-11: 2C60-2C6Y]P18031PTPN1
T16347DI0308Obesity[ICD-11: 5B80-5B81]P18031PTPN1
T16347DI0417Type 2 diabetes mellitus[ICD-11: 5A11]P18031PTPN1
T49156DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P17706PTPN2
T72702DI0075Cervical cancer[ICD-11: 2C77]P13726F3

Copyright © 2025